Recent Progress in Research on Anticancer Activities of Ginsenoside-Rg3
![]() |
Nam, Ki Yeul
(College of Agric. & Life Science, Chungnam National University)
Choi, Jae Eul (College of Agric. & Life Science, Chungnam National University) Hong, Se Chul (International Ginseng & Herb Research Institute) Pyo, Mi Kyung (International Ginseng & Herb Research Institute) Park, Jong Dae (International Ginseng & Herb Research Institute) |
1 | Huang, J. Y., Sun, Y., Fan, Q. X. and Zhang, Y. Q. (2009) Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 7: 1047-1051. DOI ScienceOn |
2 |
Hu, S. S., Zhou, L. K., Ba, Y., Li, H. L. and Zhu, C. H. (2011) A meta-analysis of ginsenoside |
3 | Zhang, J., Zhou, F., Wu, X., Zhang, X., Chen, Y., Zha, B. S., Niu, F., Lu, M., Hao, G., Sun, Y., Sun, J., Peng, Y. and Wang, G. (2012b) Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br. J. Pharmacol. 165: 120-134. DOI ScienceOn |
4 |
Yang, L. Q., Wang, B., Gan, H., Fu, S. T., Zhu, X. X., Wu, Z. N., Zhan, D. W., Gu, R. L., Dou, G. F. and Meng, Z. Y. (2012) Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside |
5 |
Liu, J. P., Lu, D., Nicholson, R. C., Zhao, W. J., Li, P. Y. and Wang, F. (2012) Toxicity of a novel anti-tumor agent 20(S)- ginsenoside |
6 |
Chen, Z. J., Cheng, J., Huang, Y. P., Han, S. L., Liu, N. X., Zhu, G. B. and Yao, J. G. (2007b) Effect of adjuvant chemotherapy of ginsenoside |
7 |
Sun, Y., Lin, H., Zhu, Y., Feng, J., Chen, Z., Li, G., Zhang, X., Zhang, Z., Tang, J., Shi, M., Hao, X. and Han, H. (2006) A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing |
8 |
Lu, P., Su, W., Miao, Z.H., Niu, H. R., Liu, J. and Hua, Q. L. (2008) Effect and mechanism of ginsenoside |
9 |
Sato, K., Mochizuki, M., Saiki, I., Yoo, Y. C., Samukawa, K. and Azuma, I. (1994) Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside- |
10 | Sengupta, S., Toh, S. A., Sellers, L. A., Skepper, J. N., Koolwijk, P., Leung, H. W., Yeung, H. W., Wong, R. N. S., Sasisekharan, R. and Fan, T. P. D. (2004) Modulating agiogenesis the yin and the yang in ginseng. Circulation. 110: 1219-1225. DOI ScienceOn |
11 | Nomi, M., Atala, A., Coppi, P. D. and Soker, S. (2002) Principals of neovascularization for tissue engineering. Mol. Aspects Med. 23: 463-483. DOI ScienceOn |
12 | Zisch, A. H., Lutolf, M. P., Ehrbar, M., Raeber, G. P., Rizzi, S. C., Davies, N., Schmökel, H., Bezuidenhout, D., Djonov, V., Zilla, P. and Hubbell, J. A. (2003) Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB. J. 17: 2260-2262. |
13 |
Kwon, H. Y., Kim, E. H., Kim, S. W., Kim, S. N., Park, J. D. and Rhee, D. K. (2008) Selective toxicity of ginsenoside |
14 | Gomes, F. G., Nedel, F., Alves, A. M., Nör, J. E. and Tarquinio, S. B. (2013) Tumor angiogenesis and lymphangiogenesis: Tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci. 92: 101-107. DOI ScienceOn |
15 |
Kwok, H. H., Guo, G. L., Lau, J. K. C., Cheng, Y. K., Wang, J. R., Jiang, Z. H., Keung, M. H., Mak, N. K. B., Yue, P. Y. K. and Wong, R. N. S. (2012) Stereoisomers ginsenosides- 20(S)- |
16 |
Kim, N. D., Kim, E. M., Kang, K. W., Cho, M. K., Choi, S. Y. and Kim, S. G. (2003) Ginsenoside |
17 |
Choi, Y. J., Lee, H. J., Kang D. W., Han, I. H., Choi, B. K. and Cho, W. H. (2013) Ginsenoside |
18 | Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Nati. Cancer Inst. 82: 4-6. DOI |
19 | Bando, H. (2007) Vascular endothelial growth factor and bevacitumab in breast cancer. Breast Cancer. 14: 163-173. DOI ScienceOn |
20 |
Yue, P. Y., Wong, D. Y., Wu, P. K., Leung, P. Y., Mak, N. K., Yeung, H. W., Liu, L., Cai, Z., Jiang, Z. H., Fan, T. P. and Wong, R. N. (2006) The angiosuppressive effects of 20(R)- ginsenoside |
21 |
Kim, J. W., Jung, S. Y., Kwon, Y. H., Lee, J. H., Lee, Y. M., Lee, B. Y. and Kwon, S. M. (2012a) Ginsenoside |
22 |
Xu, T. M., Xin, Y., Cui, M. H., Jiang, X. and Gu, L. P. (2007) Inhibitory effect of ginsenoside |
23 |
Chen, Q. J., Zhang, M. Z. and Wang, L. X. (2010) Gensenoside |
24 | Kim, Y. M., Namkoong, S., Yun, Y. G., Hong, H. D., Lee, Y. C., Ha, K. S., Lee, H., Kwon, H. J., Kwon, Y. G. and Kim, Y. M. (2007) Water extract of korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol. Pharm. Bull. 30: 1674-1679. DOI ScienceOn |
25 |
Wang, X., Zheng, Y. L., Li, K., Lin, N. and Fan, Q. X. (2009) Ginsenoside |
26 |
Xu, T. M., Cui, M. H., Xin, Y., Gu, L. P., Jiang, X. Su, M. M., Wang, D. D. and Wang, W. J. (2008) Inhibitory effect of ginsenoside |
27 | Deryugina, E. and Quigley, J. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Meta. Rev. 25: 9-34. DOI ScienceOn |
28 |
Park, D. S., Bae, D. K., Jeon, J. H., Lee, J. S., Oh, N. G., Yang, G. E., Yang, Y. H., Kim, T. K., Song, J., Lee, S. H., Song, B. S., Jeon, T. H., Kang, S. J., Joo, S. S., Kim, S. U. and Kim, Y. B. (2011) Immunopotentiation and antitumor effects of a ginsenoside |
29 |
Mochizuki, M., Yoo, Y. C. and Matsuzawa, K. (1995) Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside |
30 |
Chen, J., Peng, H., Ou-Yang, X. and He, X. (2008) Research on the antitumor effect of ginsenoside |
31 | Abdel-Wahhab, M. A., Gamil, K., El-Kady, A. A., El- Nekeety, A. A. and Naguib, K. M. (2011) Therapeutic effects of Korean red ginseng extract in Egyptian patients with chronic liver diseases. J. Gin. Res. 35: 69-79. DOI ScienceOn |
32 |
Lee, J. Y., Jung, K. H., Morgan, M. J., Kang, Y. R., Lee, H. S., Koo, G. B., Hong, S. S., Kwon, S. W. and Kim, Y. S. (2013) Sensitization of TRAIL-induced cell death by 20(S)- ginsenoside |
33 |
Chen, X.P., Qian, L. L., Jiang, H. and Chen, J. H. (2011) Ginsenoside |
34 | Park, I. H., Piao, L. Z., Kwon, S. W., Lee, Y. J., Cho, S. Y., Park, M. K. and Park, J. H. (2002) Cytotoxic dammarane glycosides from processed ginseng. Chem. Pharm. Bull. 50: 538-540. DOI ScienceOn |
35 | Lee, J. I., Ha, Y. W., Choi, T. W., Kim, H. J., Kim, S. M., Jang, H. J., Choi, J. H., Choi, M. H., Chung, B. C., Sethi, G., Kim, S. H., Ahn, K. S., Choi, S. H., Shim, B. S. and Ahn. K. S. (2011) Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells. Planta Med. 77: 133-140. DOI ScienceOn |
36 |
Chen, D., Zhao, Y., Bai, S., Shi, Z. and Zhang, J. (2003) Effect of ginsenoside |
37 | Tang, H. B., Ren, Y. P., Zhang, J., Ma, S. H., Gao, F. and Wu, Y. P. (2007) Correlation of insulin-like growth factor-1 (IGF- 1) to angiogenesis of breast cancer in IGF-1-deficient mice. Ai Zheng. 26: 1215-1220. |
38 |
Zhang, Q., Kang, X., Yang, B., Wang, J. and Yang, F. (2008) Antiangiogenic effect of capecitabine combined with ginsenoside |
39 | Wang, C. Z., Aung, H. H., Zhang, B., Sun, S., Li, X. L., He, H., Xie, J. T., He, T. C., Du, W. and Yuan, C. S. (2008) Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res. 28: 2545-2551. |
40 |
Park, H. M., Kim, S. J., Kim, J. S. and Kang, H. S. (2012) Reactive oxygen species mediated ginsenoside |
41 |
Tao, H., Yao, M., Zou, S., Zhao, D., and Qiu, H. (2002) Effect of angiogenesis inhibitor |
42 | Park, S., Yeo, M., Jin, J. H., Lee, K. M., Kim, S. S., Choi, S. Y. and Hahm, K. B. (2007) Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig. Dis. Sci. 52: 973-982. DOI ScienceOn |
43 | Park, S., Yeo, M., Jin, J. H., Lee, K. M., Jung, J. Y., Choue, R., Cho, S. W. and Hahm, K. B. (2005) Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig. Dis. Sci. 50: 1218-1227. DOI ScienceOn |
44 |
Jiang, J. W., Chen, X. M., Chen, X. H. and Zheng, S. S. (2011) Ginsenoside |
45 |
Yu, Y., Zhang, C., Liu, L. and Li, X. (2013) Hepatic arterial administration of ginsenoside |
46 |
Zhang, C., Liu, L., Yu, Y., Chen, B., Tang, C. and Li, X. (2012a) Antitumor effects of ginsenoside |
47 |
Wei, X., Su, F., Su, X., Hu, T. and Hu, S. (2012) Stereospecific antioxidant effects of ginsenoside |
48 | Toh, D. F., Patel, D. N., Chan, E. C., Teo, A., Neo, S. Y. and Koh, H. L. (2011) Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells. Chin. Med. 24: 4-6. |
49 |
Keum, Y. S., Han, S. S., Chun, K. S., Park, K. K., Park, J. H. and Lee, S. K. (2003) Inhibitory effects of the ginsenoside |
50 | Wang, C. Z., Aung, H. H., Ni, M., Wu, J. A., Tong, R., Wicks, S., He, T. C. and Yuan, C. S. (2007) Red American ginseng:ginsenosideconstituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 73: 669-674. DOI ScienceOn |
51 | Naugler, W. E. and Karin, M. (2008) NF-kappaB and canceridentifying targets and mechanisms. Curr. opin. Genet. Dev. 18: 19-26. DOI ScienceOn |
52 |
Lee, C. K., Park, K. K. and Chung, W. Y. (2012) Ginsenoside |
53 | Yang, G., Park, D., Lee, J., Song, B. S., Jeon, T.H., Kang, S. K., Jeon, J. H., Shin, S., Jeong, H. S., Lee, H. J. and Kim, Y. B. (2011) Suppressive Effects of Red Ginseng Preparations on SW480 Colon Cancer Xenografts in Mice. Food Sci. Biotechnol. 20: 1649-1653. DOI |
54 | Hofseth, L. J. and Wargovich, M. J. (2007) Inflammation, cancer, and targets of ginseng. J. Nutr. 137: 183-185. |
55 |
Yoo, Y. I., Lee, H. S., Kim, D. H., and Han, M. J. (2009) Effect of red ginseng and its represen-tative constituents, ginsenoside |
56 |
Kim, B. J., Nah, S. Y., Jeon, J. H., SO, I. and Kim, S. J. (2011) Transient Receptor Potential Melastatin 7 Channels are Involved in Ginsenoside |
57 |
Lee, S. Y., Kim, G. T., Roh, S. H., Song, J. S, Kim, H. J., Hong, S. S., Kwon, S. W. and Park, J. H. (2009) Proteomic analysis of the anticancer effect of ginsenoside |
58 |
Chen, J. X., Peng, H. M., Pu, S. P. and Guo, Y. P. (2007a) Inducement effect of ginsenoside |
59 | Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S. and Kasem, S. (2004) NF-kappaB functions as a tumour promoter in inflammation -associated cancer. Nature. 431: 461-466. DOI ScienceOn |
60 |
Bae, J. S., Park, H. S., Park, J. W., Li, S. H. and Chun, Y. S. (2012) Red ginseng and 20(S)- |
61 | Fearnhead, N. S., Wilding, J. L. and Bodmer, W. F., (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br. Med. Bull. 64: 27-43. DOI ScienceOn |
62 | Rowley, P. T. (2005) Inherited susceptibility to colorectal cancer. Ann. Rev. Med. 56: 539-554. DOI ScienceOn |
63 |
He, B. C., Gao, J. L., Luo, X., Luo, J., Shen, J., Wang, L., Zhou, Q., Wang, Y. T., Luu, H. H., Haydon, R. C., Wang, C. Z., Du, W., Yuan, C. S., He, T. C. and Zhang, B. Q. (2011) Ginsenoside |
64 |
Kim, S. M., Lee, S. Y., Yuk, D. Y., Moon, D. C., Choi, S. S., Kim, Y., Han, S. B., Oh, K. W. and Hong, J. T. (2009) Inhibition of NF-kappaB by ginsenoside |
65 | Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA A Cancer J. Clin. 61: 69-90. DOI |
66 |
Park, M. W., Ha, J. H. and Chung, S. H. (2008) 20(S)-Ginsenoside |
67 |
Wei, X., Su, F., Su, X., Hu, T. and Hu, S. (2012) Stereospecific antioxidant effects of ginsenoside |
68 |
Kim, H. S., Lee, E. H., Ko, S. R., Choi, K. J., Park, J. H. and Im, D. S. (2004) Effects of ginsenosides |
69 | Yue, P. Y., Mak, N. K., Cheng, Y. K., Leung, K. W., Ng, T. B., Fan, D. T., Yeung, H. W., and Wong, R. N. (2007) Pharmacogenomics and the Yin/Yang actions of ginseng: antitumor, angiomodulating and steroid-like activities of ginsenosides. Chin. Med. 2: 6. DOI |
70 |
Liu, J. P., Lu, D., Nicholson, R. C., Zhao, W. J., Li, P. Y. and Wang, F. (2011) Toxicity of a novel anti-tumor agent 20(S)- ginsenoside |
71 |
Pan, X. Y., Guo, H., Han, J., Hao, F., An, Y., Xu, Y., Xiaokaiti, Y., Pan, Y. and Li, X. J. (2012) Ginsenoside |
72 |
Kim, S. M., Lee, S. Y., Cho, J. S., Son, S. M., Choi, S. S., Yun, Y. P., Yoo, H. S., Yoon, D. Y., Oh, K. W., Han, S. B. and Hong, J. T. (2010) Combination of ginsenoside |
73 |
Lee, H. U., Bae, E. A., Han, M. J. and Kim, D. H. (2005) Hepatoprotective effect of 20(S)-ginsenosides |
74 |
Mochizuki, M., Yoo, Y. C. and Matsuzawa, K. (1995) Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside |
75 |
Liu, T. G., Huang, Y., Cui, D. D., Huang, X. B., Mao, S. H., Ji, L. L., Song, H. B. and Yi, C. (2009) Inhibitory effect of ginsenoside |
76 | Kim, S. W., Kwon, H. Y., Chi, D. W., Shim, J. H., Park, J. D., Lee, Y. H., Pyo, S. and Rhee, D. K. (2003) Reversal of P-glycoprotein- mediated multidrug resistance by ginsenoside Rg(3). Biochem. Pharmacol. 65: 75-82. DOI ScienceOn |
77 |
Li, X., Guan, Y. S., Zhou, X. P., Sun, L., Liu, Y., He, Q., Fu, L. and Mao, Y. Q. (2005) Anticarcinogenic effect of 20(R)- ginsenoside |
78 |
Tian, J. W., Fu, F. H., Geng, M. Y., Jiang, Y. T., Yang, J. X., Jiang, W. L., Wang, C. Y. and Liu, K. (2005) Neuroprotective effect of 20(S)-ginsenoside |
79 |
Wang, T. F. and Meng, M. Z., (1999) Experiment for immunity effects of ginsenoside |
80 |
Kang, K. S., Yamabe, N., Kim, H. Y., Park, J. H. and Yokozawa, T. (2010) Effects of heat-processed ginseng and its active component ginsenoside 20(S)- |
81 | Yun, Y. S., Moon, H. S., Oh, Y. R., Jo, S. K., Kim, Y. J. and Yun, T. K. (1987) Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethan and benzo(a)pyrene. Cancer Detect. Prev. 1: 301-309. |
82 | Wang, C. Z., Calway, T. and Yuan, C. S. (2012) Herbal medicines as adjuvants for cancer therapeutics. AM. J. Chin. Med. 40: 657-669. DOI ScienceOn |
83 | Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., Guo, J., Chen, X. and Wang, Y. (2011) Anti-cancer natural products isolated from chinese medicinal herbs. Chin. Med. 6: 27. DOI ScienceOn |
84 | Yun, T. K., Yun, Y. S. and Han, I. W. (1983) Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect. Prev. 6: 515-525. |
85 | Fuzzati, N. (2004) Analysis methods of ginsenosides. J. Chrom B. 812: 119-133. DOI ScienceOn |
86 | Yun, T. K., Lee, Y. S., Lee, Y. H., Kim, S. I. and Yun, H. Y. (2001) Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci. 16: 6-18. DOI |
87 | Shibata, S. (2001) Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16: 28-37. DOI |
88 |
Cheng, L. Q., Na, J. R., Bang, M. H., Kim, M. K. and Yang, D. C. (2008) Conversion of major ginsenoside Rb1 to 20(S)- ginsenoside |
89 |
Shinkai, K., Akedo, H., Mukai, M., Imamura, F., Isoai, A., Kobayashi, M. and Kitagawa, I. (1996) Inhibition of in vitro tumor cell invasion by ginsenoside |
90 | Lee, W. H., Choi, J. S., Kim, H. Y., Park, J. H., Park, B. D., Cho, S. J., Lee, S. K. and Surh, Y. J. (2010) Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation. Cancer Letters 294: 74-81. DOI ScienceOn |
91 | Qi, L. W., Wang, C. Z., and Yuan, C. S. (2011) Isolation and analysis of ginseng: advances and challenges. Nat. Prod. Rep. 28: 467-495. DOI ScienceOn |
92 | Leung, K. W., Cheung, L. W., Pon, Y. L., Wong, R. N., Mak, N. K., Fan, T. P., Au, S. C., Tombran-Tink, J. and Wong, A. S. (2007) Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epitheliumderived factor through the estrogen beta receptor. Br. J. Pharmacol. 152: 207-215. DOI ScienceOn |
![]() |